INZY

Inozyme Pharma
INZY

Overview Fund Activity
Delisted

INZY was delisted on the 30th of June, 2025.

Back to rankings

80 hedge funds and large institutions have $214M invested in Inozyme Pharma in 2023 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 42 increasing their positions, 15 reducing their positions, and 9 closing their positions.

Holders
80
Holders Change
+3
Holders Change %
+3.9%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
13
Increased
42
Reduced
15
Closed
9
Calls
$1.44M
Puts
$100K
Net Calls
+$1.34M
Net Calls Change
+$891K

Top Buyers

1
BOCH
1
Blue Owl Capital Holdings
New York
$5.41M
2
BlackRock
2
BlackRock
New York
$13M
3
AAA
3
Affinity Asset Advisors
New York
$8.03M
4
SFM
4
Sphera Funds Management
Israel
$6.66M
5
Goldman Sachs
5
Goldman Sachs
New York
$1.55M

Top Sellers

1
OCA
1
Octagon Capital Advisors
New York
$1.7M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$0
3
Millennium Management
3
Millennium Management
New York
$3.88M
4
SSA
4
Schonfeld Strategic Advisors
New York
$463K
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$9.68M
Name Market Value Shares Shares
Change 		Shares
Change %
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$23.6M 5,537,500 – –
PBPIA
2
Pivotal bioVenture Partners Investment Advisor
California
$19.1M 4,494,851 – –
SI
3
Sofinnova Investments
California
$18.2M 4,280,308 – –
RSCM
4
Rock Springs Capital Management
Maryland
$15.7M 3,681,174 – –
SC
5
Samlyn Capital
New York
$14.4M 3,372,558 +127,350 +4%
EAM
6
Eventide Asset Management
Massachusetts
$13.5M 3,179,837 +54,837 +2%
BlackRock
7
BlackRock
New York
$13M 3,042,330 +802,588 +36%
NMC
8
NEA Management Company
Maryland
$10.4M 2,437,689 – –
Vanguard Group
9
Vanguard Group
Pennsylvania
$10.2M 2,385,022 +108,937 +5%
Fidelity Investments
10
Fidelity Investments
Massachusetts
$9.68M 2,272,306 -192,926 -8%
AAA
11
Affinity Asset Advisors
New York
$8.03M 1,885,802 +505,950 +37%
SFM
12
Sphera Funds Management
Israel
$6.66M 1,562,907 +328,000 +27%
SB
13
Samsara BioCapital
California
$6.66M 1,562,500 – –
BOCH
14
Blue Owl Capital Holdings
New York
$5.41M 1,270,027 +1,270,027 New
Geode Capital Management
15
Geode Capital Management
Massachusetts
$4.4M 1,032,716 +209,893 +26%
Millennium Management
16
Millennium Management
New York
$3.88M 911,465 -415,406 -31%
State Street
17
State Street
Massachusetts
$3.18M 746,533 +118,186 +19%
DMKJ
18
David M. Knott Jr
$2.41M 564,549 +110,541 +24%
LCM
19
Laurion Capital Management
New York
$2.37M 557,329 -120,000 -18%
Northern Trust
20
Northern Trust
Illinois
$1.81M 424,707 +90,060 +27%
OCA
21
Octagon Capital Advisors
New York
$1.7M 400,000 -900,000 -69%
Goldman Sachs
22
Goldman Sachs
New York
$1.55M 363,372 +309,484 +574%
MB
23
MPM BioImpact
Massachusetts
$1.38M 323,813 -3,108 -1%
WP
24
Woodline Partners
California
$1.28M 300,000 +300,000 New
KCM
25
Kennedy Capital Management
Missouri
$1.22M 287,537 +287,537 New
1
2 3 4